IN2014DN07797A - - Google Patents

Info

Publication number
IN2014DN07797A
IN2014DN07797A IN7797DEN2014A IN2014DN07797A IN 2014DN07797 A IN2014DN07797 A IN 2014DN07797A IN 7797DEN2014 A IN7797DEN2014 A IN 7797DEN2014A IN 2014DN07797 A IN2014DN07797 A IN 2014DN07797A
Authority
IN
India
Prior art keywords
disintegrating
components
tablet
wet granulation
component
Prior art date
Application number
Other languages
English (en)
Inventor
Takahiro Hiramura
Kiyoshi Ikura
Sae Ishikawa
Tomohito Okabayashi
Naohiro Hashikawa
Tetsuro Morita
Kimiko Ikeda
Haruka WAKAYAMA
Original Assignee
Daicel Corp
Nichirin Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49260166&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN07797(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daicel Corp, Nichirin Chemical Ind filed Critical Daicel Corp
Publication of IN2014DN07797A publication Critical patent/IN2014DN07797A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
IN7797DEN2014 2012-03-29 2013-03-27 IN2014DN07797A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2012075832 2012-03-29
JP2012206896 2012-09-20
JP2012206895 2012-09-20
JP2012275942 2012-12-18
PCT/JP2013/059083 WO2013146917A1 (ja) 2012-03-29 2013-03-27 酸型カルボキシメチルセルロースを含む崩壊性粒子組成物の製造方法、並びに、該組成物及び該組成物を含む口腔内崩壊錠剤

Publications (1)

Publication Number Publication Date
IN2014DN07797A true IN2014DN07797A (es) 2015-05-15

Family

ID=49260166

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7797DEN2014 IN2014DN07797A (es) 2012-03-29 2013-03-27

Country Status (8)

Country Link
US (2) US20150174075A2 (es)
EP (1) EP2832350B1 (es)
JP (1) JP5996633B2 (es)
KR (1) KR101707938B1 (es)
CN (1) CN104080443B (es)
IN (1) IN2014DN07797A (es)
TW (1) TWI610691B (es)
WO (1) WO2013146917A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104010663B (zh) 2012-09-20 2021-02-19 株式会社大赛璐 含酸式羧甲基纤维素和结晶纤维素的崩解性颗粒组合物及含该组合物的口腔内崩解片剂
WO2015005241A1 (ja) * 2013-07-06 2015-01-15 株式会社ダイセル 超速崩壊錠剤及びその製造方法
US9974738B2 (en) 2013-09-27 2018-05-22 Daicel Corporation Disintegrating particle composition produced by two-stage wet granulation process, and intraorally disintegrating tablet containing same composition
EP3050560A4 (en) * 2013-09-27 2017-04-05 Daicel Corporation Intraorally disintegrable tablet comprising disintegrable granular composition
JP2017036214A (ja) * 2013-12-10 2017-02-16 株式会社ダイセル 炭酸塩を含む口腔内崩壊錠剤用組成物及び口腔内崩壊錠剤
CN106255512B (zh) * 2014-04-21 2021-01-01 株式会社大赛璐 含有微小纤维状纤维素的崩解性颗粒组合物
JP2017226600A (ja) * 2014-10-16 2017-12-28 株式会社ダイセル 超速崩壊錠剤
EP3225256B1 (en) 2014-11-24 2020-11-25 Daicel Corporation Disintegrative particle composition including pulverized lactose or granulated lactose
JPWO2016098459A1 (ja) * 2014-12-17 2017-09-28 株式会社ダイセル 遅延崩壊性粒子組成物
EP3238712B1 (en) * 2014-12-25 2023-11-01 Daicel Corporation Very rapidly disintegrating tablet, and method for producing same
JP5897196B1 (ja) * 2015-10-05 2016-03-30 大同化成工業株式会社 糖又は糖アルコール、膨潤型結合剤、崩壊剤及び高吸収性賦形剤を含む複合化造粒物及びその製造方法
WO2018021265A1 (ja) 2016-07-27 2018-02-01 沢井製薬株式会社 口腔内崩壊錠添加用組成物
JP6651638B2 (ja) 2016-09-06 2020-02-19 沢井製薬株式会社 口腔内崩壊錠添加用組成物
JPWO2020022053A1 (ja) * 2018-07-25 2021-08-02 株式会社ダイセル 微小繊維状セルロースを含み、賦形剤は含まない崩壊性粒子組成物
JP7360460B2 (ja) * 2019-06-07 2023-10-12 あゆみ製薬株式会社 口腔内崩壊錠及びその製造方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2851453A (en) * 1954-08-09 1958-09-09 Smith Kline French Lab Cellulose derivative product, compositions comprising the same and their preparation
JP4284017B2 (ja) * 2000-10-06 2009-06-24 武田薬品工業株式会社 固形製剤
WO2002030400A1 (fr) * 2000-10-06 2002-04-18 Takeda Chemical Industries, Ltd. Preparations solides
JP4551627B2 (ja) 2003-02-28 2010-09-29 東和薬品株式会社 口腔内崩壊錠剤の製造方法
KR101465803B1 (ko) * 2005-08-10 2014-11-26 시오노기세이야쿠가부시키가이샤 구강내 붕괴 정제
JP5766899B2 (ja) * 2007-04-11 2015-08-19 ニプロ株式会社 口腔内崩壊剤及びその製造方法
JP2008285434A (ja) 2007-05-16 2008-11-27 Taisho Pharm Ind Ltd 口腔内速崩壊錠
EP2251005B1 (en) * 2008-02-13 2012-10-10 Dainippon Sumitomo Pharma Co., Ltd. Orally disintegrating tablets
KR101753411B1 (ko) * 2008-11-25 2017-07-03 미쓰비시 타나베 파마 코퍼레이션 구강 내 속붕괴성정 및 그의 제조 방법
JP5674666B2 (ja) * 2009-08-11 2015-02-25 富士化学工業株式会社 崩壊性粒子組成物及び口腔内速崩壊錠
US20110150989A1 (en) * 2009-12-22 2011-06-23 Mallinkckrodt Inc. Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
JP6073543B2 (ja) 2010-07-08 2017-02-01 沢井製薬株式会社 ロラタジン含有口腔内崩壊錠の製造方法
JP5630902B2 (ja) * 2010-08-26 2014-11-26 沢井製薬株式会社 ゾルピデム酒石酸塩含有口腔内崩壊錠の製造方法
US9974738B2 (en) * 2013-09-27 2018-05-22 Daicel Corporation Disintegrating particle composition produced by two-stage wet granulation process, and intraorally disintegrating tablet containing same composition

Also Published As

Publication number Publication date
CN104080443A (zh) 2014-10-01
TWI610691B (zh) 2018-01-11
JP5996633B2 (ja) 2016-09-21
KR101707938B1 (ko) 2017-02-17
US20150174075A2 (en) 2015-06-25
US20150045452A1 (en) 2015-02-12
EP2832350A4 (en) 2015-11-18
US20200038332A1 (en) 2020-02-06
KR20140144249A (ko) 2014-12-18
EP2832350B1 (en) 2019-07-17
EP2832350A1 (en) 2015-02-04
CN104080443B (zh) 2017-12-12
WO2013146917A1 (ja) 2013-10-03
JPWO2013146917A1 (ja) 2015-12-14
TW201400145A (zh) 2014-01-01

Similar Documents

Publication Publication Date Title
IN2014DN07797A (es)
WO2014014835A3 (en) Criystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
MX2019004568A (es) Produccion mejorada de derivados de acidos grasos.
IN2013MN02445A (es)
BR112012011995A2 (pt) uso de prostaglandinas f2alfa e análogos para a cicatrização de lesões da córnea e conjuntiva.
MX2015008427A (es) Proceso de granulacion en seco para producir composiciones de comprimidos de metformina y sus composiciones.
NZ628964A (en) Supercritical hydrolysis of biomass
MX2016004472A (es) Jarabe aglutinante y adhesivo del proceso de fermentación de biomasa lignocelulósica.
IN2013CN09704A (es)
IN2015DN02907A (es)
BR112013026297A2 (pt) ésteres de resina de colofônia para não tecidos
WO2012101429A3 (en) A pellet
NZ607149A (en) Galacto-oligosaccharide-containing composition and a method of producing it
NZ593787A (en) Lyophilised dabigatran
WO2014199322A3 (en) Wear resistant compositions with low particulate contamination and method of making those compositions
PH12015500794A1 (en) Monohydrate crystal of fimasartan potassium salt, method for preparing same, and pharmacological composition comprising same
TR201009167A2 (tr) Sefalosporin içeren farmasötik granüller.
CA2876532C (en) Process for producing cell culture media
MX359554B (es) Microesferas cristalinas y proceso para fabricacion de las mismas.
IN2014DN09313A (es)
MX368061B (es) Proceso de radioetiquetado.
TR201103625A1 (tr) Sefuroksim içeren tablet formülasyonu üretim prosesi.
WO2012159981A3 (en) PROCESS FOR THE PREPARATION OF α-SUBSTITUTED KETONES AND THEIR APPLICATION IN SYNTHESIS OF PHARMACEUTICALLY ACTIVE COMPOUNDS
MX346497B (es) Compuestos para la diferenciacion de celulas madre mejorada en hepatocitos.
BR112012011994A2 (pt) método para produzir grânulos detergentes